Galil Genetic Analysis recently began offering its OncoGenetics RDMGGA 1.0 Re-sequencing Chip as a service to its customers in Israel, according to the company's CEO.
The partnership is one of several for TessArae, which has traditionally served the infectious disease-testing market, but has recently begun offering services to genetic disease-testing firms.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
